Precision Optics (POCI) Stock Price, News & Analysis

Company Overview

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

Key Stats

• Today's Range: $4.03 to $4.37
• 50-Day Range: $4.20 to $4.92
• 52-Week Range: $3.47 to $5.48
• Volume: 19,567 shs
• Average Volume: 15,520 shs
• Market Capitalization: $32.50 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Precision Optics Stock Analysis - MarketRank™

Precision Optics scored higher than 18% of companies evaluated by MarketBeat, and ranked 878th out of 948 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Precision Optics.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Precision Optics is -4.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Precision Optics is -4.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Precision Optics has a P/B Ratio of 2.60. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.92% of the float of Precision Optics has been sold short.

Short Interest Ratio / Days to Cover

Precision Optics has a short interest ratio ("days to cover") of 6.5.

Change versus previous month

Short interest in Precision Optics has recently decreased by 15.41%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Precision Optics does not currently pay a dividend.

Dividend Growth

Precision Optics does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.92% of the float of Precision Optics has been sold short.

Short Interest Ratio / Days to Cover

Precision Optics has a short interest ratio ("days to cover") of 6.5.

Change versus previous month

Short interest in Precision Optics has recently decreased by 15.41%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.9 / 5
• News Sentiment: 0.95

News Sentiment

Precision Optics has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Precision Optics this week, compared to 1 article on an average week.

Search Interest

1 people have searched for POCI on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added Precision Optics to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Precision Optics insiders have not sold or bought any company stock.

Percentage Held by Insiders

16.30% of the stock of Precision Optics is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 13.71% of the stock of Precision Optics is held by institutions.

POCI Stock Analysis - Frequently Asked Questions

How have POCI shares performed this year?

Precision Optics' stock was trading at $4.82 at the beginning of the year. Since then, POCI shares have decreased by 13.7% and is now trading at $4.1610.

How were Precision Optics' earnings last quarter?

Precision Optics Corp. (NASDAQ:POCI) released its quarterly earnings data on Monday, September, 29th. The company reported ($0.18) EPS for the quarter. The business earned $6.18 million during the quarter. Precision Optics had a negative net margin of 30.28% and a negative trailing twelve-month return on equity of 51.33%.
Read the conference call transcript.

How do I buy shares of Precision Optics?

Shares of POCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Precision Optics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Precision Optics investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

• Last Earnings: 9/29/2025
• Today: 10/14/2025
• Next Earnings (Estimated): 10/29/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:POCI
• CIK: 867840
• Web: www.poci.com
• Phone: (978) 630-1800
• Fax: 978-630-1487
• Employees: 80
• Year Founded: 1982

Profitability

• EPS (Trailing Twelve Months): ($0.84)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$5.78 million
• Net Margins: -30.28%
• Pretax Margin: -30.27%
• Return on Equity: -51.33%
• Return on Assets: -31.18%

Debt

• Debt-to-Equity Ratio: 0.11
• Current Ratio: 1.64
• Quick Ratio: 1.06

Sales & Book Value

• Annual Sales: $19.09 million
• Price / Sales: 1.71
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.60 per share
• Price / Book: 2.65

Miscellaneous

• Outstanding Shares: 7,710,000
• Free Float: 6,457,000
• Market Cap: $32.69 million
• Optionable: Not Optionable
• Beta: 0.36